Judge dismisses hormone case against Wyeth

NEW YORK, Oct 30 (Reuters) - A judge in Minnesota has dismissed a product liability lawsuit against Wyeth (WYE.N: Quote, Profile, Research, Stock Buzz), granting the drugmaker's motion for summary judgment in a case in which a woman blamed the company's hormone replacement therapy for her breast cancer, Wyeth said on Tuesday.

In dismissing the case that had been scheduled to go to trial in January, Judge George McGunnigle of the Hennepin County District Court in Minneapolis found that the plaintiff, Patricia Zandi, had not offered any scientifically valid evidence to support her claim that she had developed breast cancer as a result using Wyeth's Premarin and Prempro.

Wyeth is facing more than 5,000 lawsuits from those who believe they were harmed by the hormone replacement drugs, which have been used by millions of women to control the effects of menopause. (Reporting by Bill Berkrot, editing by Gerald E. McCormick)